β-adrenergic and endothelin receptor interaction in dilated human cardiomyopathic myocardium

Journal of Cardiac Failure

Volumn 7, Issue 2, 2001, Pages 129-137

  Walker, C A ^a   Ergul, A ^a   Grubbs, A ^a   Zile, M R ^a   Zellner, J L ^a   Crumbley, A J ^a   Spinale, F G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Congestive heart failure; Endothelin; adrenergic receptor

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYCLIC AMP; ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; FORSKOLIN; ISOPRENALINE;

ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART DILATATION; HEART MUSCLE FIBER MEMBRANE; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

EID: 0034989159     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1054/jcaf.2001.24125     Document Type: Article

References (40)

1. Hormones and hemodynamics in heart failure
2. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts
3. Beta-adrenergic receptors in failing human myocardium
4. Plasma endothelin-1 levels in idiopathic dilated cardiomyopathy
5. Plasma endothelin in chronic heart failure
6. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology
7. Exogenous effects and endogenous production of endothelin in cardiac myocytes: Potential significance in heart failure
8. The effects of endothelin-A receptor blockade during the progression of pacing-induced congestive heart failure
9. Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure
10. Beta-adrenergic receptors and receptor signaling in heart failure
11. Endothelin receptor subtypes and their role in transmembrane signaling mechanisms
12. Molecular identification of guanine-nucleotide-binding regulatory proteins which couple to endothelin receptors
13. Endothelin ETA receptor regulates signaling and ANF gene expression via multiple G protein-linked pathways
14. Coupling of two endothelin receptor subtypes to differing, signal transduction in transfected Chinese hamster ovary cells
15. Endothelin inhibits adenylyl cyclase and stimulates phosphoinositide hydrolysis in adult cardiac myocytes
16. Endothelin ETA-receptors couple to inositol phosphate formation and inhibition of adenylate cyclase in human right atrium
17. Endothelin receptor type A signals both the accumulation of inositol phosphates and the inhibition of cyclic AMP generation in rat myometrium: Stimulation and desensitization
18. Myocardial matrix metalloproteinase activity and abundance with congestive heart failure
19. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: Coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor downregulation in heart failure
20. Myocardial Na+, K(+)-ATPase in tachycardia induced cardiomyopathy
21. The cellular basis for the blunted response to beta-adrenergic stimulation in supraventricular tachycardia-induced cardiomyopathy
22. Endothelin stimulates multiple responses in isolated adult ventricular cardiac myocytes
23. Gender differences in the expression of endothelin receptors in human saphenous veins in vitro
24. Clinical significance of endothelin in cardiovascular disease
25. Endothelin as a regulator of cardiovascular function in health and disease
26. Endothelin-1 in the myocardial interstitium in heart failure: Relation to myocyte endothelin converting enzyme activity and expression
27. Basal and isoprenaline-stimulated cAMP content in failing versus nonfailing cardiac preparations
28. cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium
29. Type-specific regulation of mammalian adenylyl cyclases by G protein pathways
30. Increase in myocardial Gi-proteins in heart failure
31. Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure
32. Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing
33. Neurohumoral mechanisms in heart failure: Role in pathogenesis, therapy, and drug tolerance
34. The neurohumoral axis in congestive heart failure
35. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metoprolol CR/XL Randomized Intervention in congestive heart failure (MERIT-HF)
36. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure
37. Endothelin receptors in the failing and nonfailing human heart
38. Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure
39. Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy: Endothelin-1 system in the human failing heart
40. Aspartate mutation distinguishes ETA but not ETB receptor subtype-selective ligand binding while abolishing phospholipase C activation in both receptors